Search Results - "Pybus BS"

Reduced cytochrome P-450 (CYP) 2D6 activity and Plasmodium vivax malaria risk in Amazonians: A retrospective, population-based cohort study.

Authors: Corder, Rodrigo M. Puça, Maria Carolina S. B. Prete, Carlos A. et al.

Source: PLoS Neglected Tropical Diseases. 3/27/2026, Vol. 20 Issue 3, p1-14. 14p.

Potent acridone antimalarial against all three life stages of Plasmodium.

Authors: Kancharla P Dodean RA Li Y et al.

Source: Nature communications [Nat Commun] 2026 Apr 14; Vol. 17 (1). Date of Electronic Publication: 2026 Apr 14.

Publication Type: Journal Article

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

A six-pronged approach to manage a Plasmodium vivax outbreak in a low- and middle-income country on the road to malaria elimination.

Authors: Labadie-Bracho, Mergiory Baldewsingh, Gaitree K. Hiwat van Laar, Hélène et al.

Source: PLoS Neglected Tropical Diseases. 2/13/2026, Vol. 20 Issue 2, p1-15. 15p.

Amplicon-based DNA sequencing to characterize Duffy antigen polymorphisms and analysis of Duffy blood system and glucose-6-phosphate dehydrogenase deficiency in Mauritania.

Authors: Fontaine, Albin Djigo, Oum Kelthoum Mamadou Gomez, Nicolas et al.

Source: PLoS Neglected Tropical Diseases. 12/26/2025, Vol. 19 Issue 12, p1-22. 22p.

Methaemoglobin as a surrogate marker of primaquine antihypnozoite activity in Plasmodium vivax malaria: A systematic review and individual patient data meta-analysis.

Authors: Fadilah, Ihsan Commons, Robert J. Chau, Nguyen Hoang et al.

Source: PLoS Medicine. 9/27/2024, Vol. 21 Issue 9, p1-20. 20p.

Single low dose primaquine to block the transmission of Plasmodium falciparum—proposed stand-alone and ACT-adapted regimens.

Authors: Taylor, Walter R. J. Olupot-Olupot, Peter Onyamboko, Marie A. et al.

Source: BMC Medicine. 7/1/2025, Vol. 23 Issue 1, p1-11. 11p.

Potent Acridone Antimalarial against All Three Life Stages of Plasmodium.

Authors: Kancharla P Dodean RA Li Y et al.

Source: Research square [Res Sq] 2025 Jun 27. Date of Electronic Publication: 2025 Jun 27.

Publication Type: Journal Article; Preprint

Journal Info: Country of Publication: United States NLM ID: 101768035 Publication Model: Electronic Cited Medium: Internet ISSN: 2693-5015 (Electronic) Linking ISSN: 26935015 NLM ISO Abbreviation: Res Sq Subsets: PubMed not MEDLINE

Plasma folate dynamics in Plasmodium falciparum-infected African children treated with artemisinin combination therapy and single low-dose primaquine or placebo.

Authors: Ajayi, Seun Onyamboko, Marie A. Olupot-Olupot, Peter et al.

Source: Malaria Journal. 10/15/2025, Vol. 24 Issue 1, p1-10. 10p.

Bioequivalence of a new coated 15 mg primaquine formulation for malaria elimination.

Authors: Nguyen Ngoc Pouplin, Julie Kaendiao, Thoopmanee Rahimi, Bilal Ahmad et al.

Source: Malaria Journal. 6/5/2024, Vol. 23 Issue 1, p1-11. 11p.

Population pharmacokinetics of primaquine and its metabolites in African males.

Authors: Chotsiri, Palang Mahamar, Almahamoudou Diawara, Halimatou et al.

Source: Malaria Journal. 5/21/2024, Vol. 23 Issue 1, p1-12. 12p.

Development of weight and age-based dosing of daily primaquine for radical cure of vivax malaria.

Authors: Taylor, Walter Robert Hoglund, Richard M. Peerawaranun, Pimnara et al.

Source: Malaria Journal. 9/9/2021, Vol. 20 Issue 1, p1-10. 10p.

Increased primaquine total dose prevents Plasmodium vivax relapses in patients with impaired CYP2D6 activity: report of three cases.

Authors: de Pina-Costa, Anielle Silvino, Ana Carolina Rios dos Santos, Edwiges Motta et al.

Source: Malaria Journal. 8/14/2021, Vol. 20 Issue 1, p1-6. 6p.

Enhancing CYP2D6 genotyping with nanopore sequencing to address allele diversity P. vivax malaria elimination.

Authors: Wongsurawat, Thidathip Jenjaroenpun, Piroon Suwannasin, Kanokon et al.

Source: Scientific Reports. 9/30/2025, Vol. 15 Issue 1, p1-17. 17p.

Cytochrome P450 2D6 (CYP2D6) and glucose-6-phosphate dehydrogenase (G6PD) genetic variations in Thai vivax malaria patients: Implications for 8-aminoquinoline radical cure.

Authors: Chamchoy, Kamonwan Sudsumrit, Sirapapha Thita, Thanyapit et al.

Source: PLoS Neglected Tropical Diseases. 12/12/2022, Vol. 16 Issue 12, p1-20. 20p.

Genotypes and phenotypes of G6PD deficiency among Indonesian females across diagnostic thresholds of G6PD activity guiding safe primaquine therapy of latent malaria.

Authors: Satyagraha, Ari Winasti Sadhewa, Arkasha Panggalo, Lydia Visita et al.

Source: PLoS Neglected Tropical Diseases. 7/16/2021, Vol. 15 Issue 7, p1-15. 15p.

Protocol for a multicentric open-label randomized controlled trial comparing low-dose (0.25 mg/kg) and standard-dose (0.75 mg/kg) primaquine for gametocytocidal efficacy and safety in Plasmodium falciparum malaria.

Authors: Gulati P Singhal R Gupta A et al.

Source: Malaria journal [Malar J] 2026 May 07; Vol. 25 (1). Date of Electronic Publication: 2026 May 07.

Publication Type: Clinical Trial Protocol; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101139802 Publication Model: Electronic Cited Medium: Internet ISSN: 1475-2875 (Electronic) Linking ISSN: 14752875 NLM ISO Abbreviation: Malar J Subsets: MEDLINE

Natural products as transmission-blocking agents against malaria: a comprehensive review of bioactive compounds and their therapeutic potential.

Authors: Fokou, Patrick Valere Tsouh Tali, Mariscal Brice Tchatat Mbouna, Cedric Derick Jiatsa et al.

Source: Malaria Journal. 5/26/2025, Vol. 24 Issue 1, p1-22. 22p.

Direct oral anticoagulant concentrations and adherence in stroke patients.

Authors: Aakerøy, Rachel Gynnild, Mari Nordbø Løfblad, Lena et al.

Source: Basic & Clinical Pharmacology & Toxicology. Jan2024, Vol. 134 Issue 1, p175-185. 11p.

Synthesis and antifungal and antitumor activities of acridine-containing tetrahydronaphthalene spiroisoxazoline derivatives.

Authors: Pang T Zhao Y Li Y et al.

Source: Molecular diversity [Mol Divers] 2026 Aug; Vol. 30 (4), pp. 6205-6219. Date of Electronic Publication: 2026 Mar 25.

Publication Type: Journal Article

Journal Info: Publisher: ESCOM Science Publishers Country of Publication: Netherlands NLM ID: 9516534 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-501X (Electronic) Linking ISSN: 13811991 NLM ISO Abbreviation: Mol Divers Subsets: MEDLINE

Discovery of Imidazole-Based Inhibitors of Plasmodium falciparum cGMP-Dependent Protein Kinase.

Authors: Bheemanaboina RRY de Souza ML Gonzalez ML et al.

Source: ACS medicinal chemistry letters [ACS Med Chem Lett] 2021 Nov 15; Vol. 12 (12), pp. 1962-1967. Date of Electronic Publication: 2021 Nov 15 (Print Publication: 2021).

Publication Type: Journal Article

Journal Info: Publisher: American Chemical Society Country of Publication: United States NLM ID: 101521073 Publication Model: eCollection Cited Medium: Print ISSN: 1948-5875 (Print) Linking ISSN: 19485875 NLM ISO Abbreviation: ACS Med Chem Lett Subsets: PubMed not MEDLINE